Skip to main content
All lobbying filings

Arentfox Schiff LLP

Arentfox Schiff LLP filed a Q3 report for Transparency-RX Corp. on October 17, 2025, reporting $20,000 in lobbying income.

Lobbying for Transparency-RX Corp. · Coalition of licensed transparent pharmacy benefit managers

As filed: ARENTFOX SCHIFF LLP for TRANSPARENCY-RX CORP.

All filings by Arentfox Schiff LLP · Everything Transparency-RX Corp. has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 17, 2025
Income
$20,000
What the client paid this registrant for the period.
Client based in
Virginia

Official filing document

 Lobbyists on this filing 1
  • BLAKE THELANDER New on this filing
    Previously held: Health Policy Advisor/Legislative Director, Rep. Mariannette Miller-Meeks (2023-2025), Staff Assistant/Legislative Assistant/Senior Legislative Assistant, Rep. Jefferson Van Drew (2020-2023), Intern, Rep. Ralph Norman (2019-2019)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

Pharmacy Benefit Manager reform Transparency in prescription drug markets Prescription drug prices S. 891 (Bipartisan Health Care Act), regarding Pharmacy Benefit Manager reform, transparency in prescription drug markets, and prescription drug prices

 Bills named in this filing 1
  • S. 891
    Bipartisan Health Care Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem